Purpose: Gallbladder polyps are often found in clinical examination, of which cholesterol polyps (CPs) account for the vast majority. However, there is limited evidence-based guidance on the management of CPs patients. This study aimed to determine the risk factors for CPs formation and provide bases for optimizing treatment and prevention strategies.Methods: In this multicenter retrospective case-control study, patients with pathologically-proven CPs between September 2018 to June 2022 were included in the CPs group. The control group included age- and gender-matched subjects sonographically diagnosed without GPs or other gallbladder lesions, randomly selected from the health checkup center in a 1:1 (CPs: control) ratio. Clinical characteristics, ultrasound findings, and laboratory examination results were reviewed and compared between the two groups to determine the risk factors for CPs.Results: In total, 3110 patients who met the inclusion criteria were equally enrolled in CPs and the control groups. The mean age of CPs patients was 41.66±13.18 years, with the highest proportion in the 30-39 years group. On multivariate analysis, triacylglycerol ≥ 2.3mmol/L, decreased high-density lipoprotein (HDL), and fatty liver were significantly associated with CPs (P < 0.001, P < 0.001 and P = 0.001, respectively). There was no strong correlation between CPs and other parameters, such as body mass index, blood pressure, total cholesterol, and liver function.Conclusion: The morbidity of CPs displayed a younger trend and was closely associated with two types of dyslipidemia: decreased HDL and increased triacylglycerol. Moreover, fatty liver was found to be an independent risk factor for CPs.